APPA Insider Trading Activity and SEC Form 4 Filings
APPA insider trading summary
No open-market insider purchases or sales of Ap Pharma Inc (APPA) have been reported on SEC Form 4 in the past 12 months.
Latest APPA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2013 | Barry D Quart | Chief Executive Officer | Buy | $400K (1,000,000 @ $0.40) |
| Jul 25, 2012 | Spch, Lllp | 10% Owner | Buy | $20.0M (38,095,238 @ $0.53) |
| Oct 19, 2009 | Tang Capital Management LLC | 10% Owner | Buy | $2.1M (2,443,181 @ $0.88) |
| Oct 19, 2009 | Tang Capital Partners LP | 10% Owner | Buy | $2.1M (2,443,181 @ $0.88) |
| Oct 19, 2009 | Kevin C Tang | Director | Buy | $2.1M (2,443,181 @ $0.88) |
| Dec 31, 2008 | Tang Capital Partners LP | 10% Owner | Buy | $73K (175,000 @ $0.41) |
| Dec 31, 2008 | Kevin C Tang | 10% Owner | Buy | $73K (175,000 @ $0.41) |
| Dec 31, 2008 | Tang Capital Management LLC | 10% Owner | Buy | $73K (175,000 @ $0.41) |
| Dec 18, 2008 | Tang Capital Partners LP | 10% Owner | Buy | $201K (415,300 @ $0.48) |
| Dec 18, 2008 | Tang Capital Management LLC | 10% Owner | Buy | $201K (415,300 @ $0.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.